Finch Therapeutics Group, Inc.
FNCH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18 | $6 | $23 | $474 |
| - Cash | $10 | $25 | $71 | $133 |
| + Debt | $28 | $30 | $52 | $6 |
| Enterprise Value | $36 | $11 | $4 | $346 |
| Revenue | $0 | $0 | $1 | $19 |
| % Growth | -100% | -87.6% | -95.4% | – |
| Gross Profit | -$0 | -$1 | -$5 | -$39 |
| % Margin | – | -1,320.6% | -539.6% | -209.1% |
| EBITDA | -$14 | -$32 | -$83 | -$58 |
| % Margin | – | -30,357% | -9,603.6% | -311.3% |
| Net Income | -$14 | -$75 | -$115 | -$58 |
| % Margin | – | -69,863.6% | -13,315.4% | -313.8% |
| EPS Diluted | -8.64 | -46.59 | -72.12 | -36.72 |
| % Growth | 81.5% | 35.4% | -96.4% | – |
| Operating Cash Flow | – | -$32 | -$75 | -$67 |
| Capital Expenditures | – | $0 | -$2 | -$16 |
| Free Cash Flow | – | -$32 | -$77 | -$83 |